Sun Pharmaceutical Industries Ltd on Wednesday reported a 16.52 per cent rise in third-quarter (Q3 FY24) profit, driven by strong sales in key markets such as the United States.
Also Read– LIC shares cross listing price for the first time
The company’s consolidated profit after tax came at Rs 2,523.75 crore for the quarter ended December 31, 2023, as against Rs 2,166.01 crore in the same period last fiscal.
The stock jumped 4.88 per cent to scale its one-year high level of Rs 1,438.50.
Source :
